Arteris (NASDAQ:AIP) Reaches New 1-Year High - Here's What Happened

Key Points

• Arteris, Inc. shares reached a new 52-week high of $14.70 during trading, closing at $14.41 with a significant trading volume of over 1.4 million shares.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Arteris with a price target of $15.00, amidst varied ratings from different firms.
• Recent insider transactions include major shareholder Bayview Legacy and CEO K Charles Janac selling 100,000 shares each at an average price of $13.10, representing a decrease in their ownership stake.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) shares hit a new 52-week high during trading on Thursday . The company traded as high as $14.70 and last traded at $14.41, with a volume of 1454469 shares trading hands. The stock had previously closed at $13.40.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on AIP shares. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. Weiss Ratings restated a "sell (d-)" rating on shares of Arteris in a research report on Wednesday, October 8th. Finally, TD Cowen raised their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Arteris currently has a consensus rating of "Moderate Buy" and a consensus target price of $15.00.

Arteris Price Performance

The company has a market cap of $614.59 million, a price-to-earnings ratio of -17.57 and a beta of 1.45. The business has a 50 day simple moving average of $10.15 and a 200 day simple moving average of $8.73.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). The business had revenue of $16.50 million for the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Insider Transactions at Arteris

In related news, major shareholder Bayview Legacy, Llc sold 100,000 shares of the stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $13.10, for a total transaction of $1,310,000.00. Following the completion of the transaction, the insider directly owned 9,739,071 shares in the company, valued at approximately $127,581,830.10. This trade represents a 1.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO K Charles Janac sold 100,000 shares of the stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $13.10, for a total value of $1,310,000.00. Following the transaction, the chief executive officer directly owned 9,739,071 shares of the company's stock, valued at $127,581,830.10. This trade represents a 1.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 811,936 shares of company stock valued at $10,100,520 in the last ninety days. Corporate insiders own 29.10% of the company's stock.

Hedge Funds Weigh In On Arteris

A number of large investors have recently made changes to their positions in AIP. Raymond James Financial Inc. acquired a new position in Arteris in the 2nd quarter valued at $32,000. CWM LLC boosted its holdings in shares of Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. acquired a new position in Arteris during the 1st quarter worth about $95,000. Savant Capital LLC acquired a new position in Arteris during the 2nd quarter worth about $97,000. Finally, Kapitalo Investimentos Ltda acquired a new position in Arteris during the 2nd quarter worth about $104,000. Institutional investors own 64.36% of the company's stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.